Page last updated: 2024-08-26

terameprocol and Lung Neoplasms

terameprocol has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giacalone, NJ; Lu, B; Sun, Y1
Dorr, RT; Lambert, JD; Meyers, RO; Timmermann, BN1

Other Studies

2 other study(ies) available for terameprocol and Lung Neoplasms

ArticleYear
Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:1

    Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Masoprocol; Radiation-Sensitizing Agents; Sp1 Transcription Factor; Survivin; Tumor Cells, Cultured; Tumor Stem Cell Assay

2011
tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo.
    Cancer letters, 2001, Sep-28, Volume: 171, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle; Colonic Neoplasms; DNA Replication; Female; Intracellular Membranes; Kidney; Liver; Lung Neoplasms; Male; Masoprocol; Melanoma; Melanoma, Experimental; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, SCID; Mitochondria; Neoplasm Transplantation; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001